| 体内研究 | Deoxyribonuclease (0.1 U; i.p.; once daily for 3 days) inhibits liver metastasis, besides results in a greater prolongation of the survival period by combining surgical removal of the primary tumour mass. XIYU has not independently confirmed the accuracy of these methods. They are for reference only. | Animal Model: | Female BALB/c x DBA/2 mice with murine tumour L5178Y-ML cells subcutaneous injection | | Dosage: | 0.1 U per mouse | | Administration: | Intravenous injection; 0.1 U; once daily for three days | | Result: | Reduced liver weight from 2.26 to 1.55 g, affected the intensity of liver metastasis, reduced the numbers and sizes of metastatic and affected tumour cell arrest. |
| Animal Model: | Female BALB/c x DBA/2 mice with murine tumour and surgical removal of subcutaneous tumours | | Dosage: | 0.1 U per mouse | | Administration: | Intravenous injection; 0.1 U; once daily for 3 days either before or after primary tumour removal | | Result: | Significantly prolongated survival after tumour cell inoculation compared to the untreated group. |
|